Antifungal Drugs Market by Infection Type, Type, Form, Therapeutic Indications - Global Forecast 2025-2030- Product Image

Sale

Antifungal Drugs Market by Infection Type, Type, Form, Therapeutic Indications - Global Forecast 2025-2030

Report
186 Pages
October 2024
Region: Global
360iResearch™
ID: 5337228

UP TO €684EUR$697USD£571GBP OFF until Dec 31^st 2024

The Antifungal Drugs Market grew from USD 14.89 billion in 2023 to USD 15.80 billion in 2024. It is expected to continue growing at a CAGR of 6.19%, reaching USD 22.69 billion by 2030.

The Antifungal Drugs market encompasses pharmaceutical formulations used to treat fungal infections, which can range from superficial to systemic and severe. These drugs are essential owing to the rising incidences of fungal infections, increasingly due to prevalent factors such as a growing immunocompromised population from conditions like HIV/AIDS, cancer therapies, and organ transplants. Applications span from clinical treatments for dermatophyte, yeast, and mold infections in hospitals and clinics to over-the-counter products for minor infections. End-use sectors primarily include hospitals, clinics, and standalone dermatology and medical care facilities. Growth in the antifungal drugs market is driven by burgeoning demand for effective fungal infection treatments, advancements in drug development, and the rising incidences of resistant fungal strains requiring novel solutions. Potential opportunities lie in the expansion of antifungal drug applications in veterinary markets and the developmental push towards effective therapies for resistant fungal strains. Companies can capitalize on these by focusing on R&D for novel antifungal agents with broader spectrums of activity and developing strategies for market penetration in emerging economies. However, growth is challenged by the limited number of novel antifungal agents, high costs of drug development, and regulatory challenges concerning drug approval processes. Additionally, the side effects associated with long-term antifungal use form a significant limitation. Innovation can be channeled into creating synthetic and natural compound-based antifungal agents, delivering drugs through nanotechnology, and exploring combination therapies for improved efficacy. The nature of the market is highly competitive, yet there's a considerable space for breakthroughs driven by scientific research and strategic collaborations between biotech firms and academic institutions. The continual adaptation to regulatory and market fluctuations will determine long-term success, positioning R&D-focused companies to potentially lead future market expansion.

Understanding Market Dynamics in the Antifungal Drugs Market

The Antifungal Drugs Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Growing prevalence of fungal infection among population worldwide
- High awareness levels pertaining to myriad fungal infections
- Favorable government approvals for antifungal drugs
Market Restraints
- Continued preference for conventional antifungal drugs
Market Opportunities
- Increased R&D funding and focus on product innovation
- Stategic alliances and partnerships for antifungal drugs
Market Challenges
- Presence of counterfeit drugs and patent expiration of branded drugs

Exploring Porter’s Five Forces for the Antifungal Drugs Market

Porter’s Five Forces framework further strengthens the insights of the Antifungal Drugs Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Antifungal Drugs Market

External macro-environmental factors deeply influence the performance of the Antifungal Drugs Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Antifungal Drugs Market

The Antifungal Drugs Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Antifungal Drugs Market

The Antifungal Drugs Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Antifungal Drugs Market

The Antifungal Drugs Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antifungal Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Astellas Pharma Inc., Bayer HealthCare Pharmaceuticals LLC, Becton, Dickinson and Company, bioMérieux SA, Cadila Pharmaceuticals Limited, Cardinal Health, Inc., Cipla, Inc., Enzon Pharmaceuticals, Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., Hologic, Inc., Johnson & Johnson, Lakewood-Amedex, Inc., Merck KGaA, Novartis AG, Pfizer, Inc., Quest Diagnostics Incorporated, SCYNEXIS, Inc., Sigma-Aldrich, Inc., and Sun Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Antifungal Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Infection Type
- Superficial Fungal Infection
- Systemic Fungal infection
Type
- Allylamines
  - Butenafine
  - Naftifine
  - Terbinafine
- Azoles
  - Imidazoles
  - Thiazoles
  - Voricanazole
- Echinocandins
  - Anidulafungin
  - Caspofungin
  - Micafungin
- Polyenes
  - Amphotericin B
  - Candicidin
  - Hamycin
  - Natamycin
Form
- Ointments
- Powder
- Tablets
Therapeutic Indications
- Aspergillosis
- Candidiasis
- Dermatophytosis

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of fungal infection among population worldwide
5.1.1.2. High awareness levels pertaining to myriad fungal infections
5.1.1.3. Favorable government approvals for antifungal drugs
5.1.2. Restraints
5.1.2.1. Continued preference for conventional antifungal drugs
5.1.3. Opportunities
5.1.3.1. Increased R&D funding and focus on product innovation
5.1.3.2. Stategic alliances and partnerships for antifungal drugs
5.1.4. Challenges
5.1.4.1. Presence of counterfeit drugs and patent expiration of branded drugs
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Antifungal Drugs Market, by Infection Type

6.1. Introduction
6.2. Superficial Fungal Infection
6.3. Systemic Fungal infection

7. Antifungal Drugs Market, by Type

7.1. Introduction
7.2. Allylamines
7.2.1. Butenafine
7.2.2. Naftifine
7.2.3. Terbinafine
7.3. Azoles
7.3.1. Imidazoles
7.3.2. Thiazoles
7.3.3. Voricanazole
7.4. Echinocandins
7.4.1. Anidulafungin
7.4.2. Caspofungin
7.4.3. Micafungin
7.5. Polyenes
7.5.1. Amphotericin B
7.5.2. Candicidin
7.5.3. Hamycin
7.5.4. Natamycin

8. Antifungal Drugs Market, by Form

8.1. Introduction
8.2. Ointments
8.3. Powder
8.4. Tablets

9. Antifungal Drugs Market, by Therapeutic Indications

9.1. Introduction
9.2. Aspergillosis
9.3. Candidiasis
9.4. Dermatophytosis

10. Americas Antifungal Drugs Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Antifungal Drugs Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Antifungal Drugs Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. ANTIFUNGAL DRUGS MARKET RESEARCH PROCESS
FIGURE 2. ANTIFUNGAL DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 11. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ANTIFUNGAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. ANTIFUNGAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. ANTIFUNGAL DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ANTIFUNGAL DRUGS MARKET DYNAMICS
TABLE 7. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY SUPERFICIAL FUNGAL INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY SYSTEMIC FUNGAL INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY BUTENAFINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY NAFTIFINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY TERBINAFINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY IMIDAZOLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY THIAZOLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY VORICANAZOLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY ANIDULAFUNGIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY CASPOFUNGIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY MICAFUNGIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY AMPHOTERICIN B, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY CANDICIDIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY HAMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY NATAMYCIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY ASPERGILLOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY CANDIDIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIFUNGAL DRUGS MARKET SIZE, BY DERMATOPHYTOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 65. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 68. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 69. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 70. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 71. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 72. CANADA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 80. MEXICO ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES ANTIFUNGAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 107. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 108. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 110. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 111. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 112. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 113. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 114. CHINA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 115. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 116. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 118. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 119. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 120. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 121. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 122. INDIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 131. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 132. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 134. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 135. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 136. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 137. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 138. JAPAN ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 162. SINGAPORE ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 171. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 177. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 179. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 180. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 182. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 183. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 184. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 185. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 186. THAILAND ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 204. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 205. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 206. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 207. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 208. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 209. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 210. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 211. DENMARK ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 212. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 213. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 215. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 216. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 217. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 218. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 219. EGYPT ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 220. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 221. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 223. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 224. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 225. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 226. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 227. FINLAND ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 228. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 229. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 231. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 232. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 233. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 234. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 235. FRANCE ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 236. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 237. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 239. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 240. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 241. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 242. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 243. GERMANY ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 251. ISRAEL ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 252. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 253. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 254. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 255. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 256. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 257. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 258. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 259. ITALY ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 276. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 277. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 278. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 279. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 280. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 281. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 282. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 283. NORWAY ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 284. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 285. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 286. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 287. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 288. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 289. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 290. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 291. POLAND ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 292. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 293. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 294. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 295. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 296. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 297. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 298. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 299. QATAR ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 324. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 325. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 326. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 327. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 328. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 329. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 330. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 331. SPAIN ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 332. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 333. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 336. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 337. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 338. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 339. SWEDEN ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 340. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 341. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 342. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 343. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 344. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 345. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 346. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 347. SWITZERLAND ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 348. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 349. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 350. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 351. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 352. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 353. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 354. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 355. TURKEY ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 356. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 357. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY ALLYLAMINES, 2018-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY AZOLES, 2018-2030 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY ECHINOCANDINS, 2018-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY POLYENES, 2018-2030 (USD MILLION)
TABLE 362. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 363. UNITED ARAB EMIRATES ANTIFUNGAL DRUGS MARKET SIZE, BY THERAPEUTIC INDICATIONS, 2018-2030 (USD MILLION)
TABLE 364. UNITED KINGDOM ANTIFUNGAL DRUGS MARKET SIZE, BY INFECTION TYPE, 2018-2030 (USD MILLION)
TABLE 365. UNITED KINGDOM ANTIFUNGAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MI

Companies Mentioned

The leading players in the Antifungal Drugs Market, which are profiled in this report, include:

Abbott Laboratories
Astellas Pharma Inc.
Bayer HealthCare Pharmaceuticals LLC
Becton, Dickinson and Company
bioMérieux SA
Cadila Pharmaceuticals Limited
Cardinal Health, Inc.
Cipla, Inc.
Enzon Pharmaceuticals, Inc.
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
Hologic, Inc.
Johnson & Johnson
Lakewood-Amedex, Inc.
Merck KGaA
Novartis AG
Pfizer, Inc.
Quest Diagnostics Incorporated
SCYNEXIS, Inc.
Sigma-Aldrich, Inc.
Sun Pharmaceutical Industries Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	186
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 15.8 Billion
Forecasted Market Value ( USD ) by 2030	$ 22.69 Billion
Compound Annual Growth Rate	6.1%
Regions Covered	Global
No. of Companies Mentioned	22

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3481EUR$3,545USD£2,904GBP €3868EUR$3,939USD£3,227GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6158EUR$6,272USD£5,138GBP €6843EUR$6,969USD£5,709GBP

Understanding Market Dynamics in the Antifungal Drugs Market

Exploring Porter’s Five Forces for the Antifungal Drugs Market

Applying PESTLE Analysis to the Antifungal Drugs Market

Analyzing Market Share in the Antifungal Drugs Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Antifungal Drugs Market

Strategic Recommendations for Success in the Antifungal Drugs Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Antifungal Drugs - Global Strategic Business Report

Antifungal Drugs Market Report by Drug Class, Indication, and Region 2024-2032

Antifungal Drugs Market Size, Share & Trends Analysis Report by Drug Class (Azoles, Polyenes), Indication (Dermatophytosis, Aspergillosis), Dosage Form, Distribution Channel, Region, and Segment Forecasts, 2024-2030

Antifungals Global Market Report 2024

Vaginal Antifungals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

About the Antifungal Drug Market